1: Sahu A, Narayanam M, Kurmi M, Ladumor MK, Singh S. Quantitation of memantine hydrochloride bulk drug and its tablet formulation using proton nuclear magnetic resonance spectrometry. Magn Reson Chem. 2016 Feb 28. doi: 10.1002/mrc.4421. [Epub ahead of print] doi: 10.1016/j.jchromb.2015.09.016. Epub 2015 Nov 5. doi: 10.1517/14656566.2014.945907. Epub 2014 Aug 1. doi: 10.3797/scipharm.1310-09. eCollection 2014 Jun. 5: Kitamura S, Nakamura Y, Homma A, Kimura N, Asami Y. Tolerability and efficacy of the long-term administration of memantine hydrochloride (Memary®) in patients with moderate to severe Alzheimer's disease. Nihon Ronen Igakkai Zasshi. 2014;51(1):74-84. doi: 10.1016/j.jstrokecerebrovasdis.2013.05.014. Epub 2013 Jun 19. doi: 10.1016/j.jocn.2013.02.041. Epub 2013 Sep 13. Review. doi: 10.3969/j.issn.1002-0829.2013.04.006. 9: Xie MF, Zhou W, Tong XY, Chen YL, Cai Y, Li Y, Duan GL. High-performance liquid chromatographic determination of memantine hydrochloride in rat plasma using sensitive fluorometric derivatization. J Sep Sci. 2011 Feb;34(3):241-6. doi: 10.1002/jssc.201000579. Epub 2011 Jan 7.